Implants News and Research

RSS

NMT Medical receives preliminary results for CLOSURE I PFO/stroke and transient ischemic attack trial

NMT Medical, Inc., an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures, today announced that it has received preliminary results for CLOSURE I, its patent foramen ovale (PFO)/stroke and transient ischemic attack (TIA) trial in the U.S.

18 Jun 2010

First implantation of PyroTITAN Humeral Resurfacing Arthroplasty performed outside US in Australia

Ascension Orthopedics, Inc., a market leader in PyroCarbon orthopedic implants, announces the first implantation of the PyroTITAN™ Humeral Resurfacing Arthroplasty outside the United States. The PyroTITAN was implanted last month in Brisbane, Australia in a 46-year-old patient who reported "immediate pain relief" within 24 hours of surgery. The PyroTITAN Humeral Resurfacing implant is the first commercially-available shoulder arthroplasty prosthesis made of PyroCarbon in the world.

17 Jun 2010

ASTRO urges MedPAC to recommend end to abuse of physician self-referral law in radiation oncology

The American Society for Radiation Oncology (ASTRO) commends the Medicare Payment Advisory Commission (MedPAC) for highlighting concerns about physician self-referral in cancer care in its report released yesterday. We urge the commission to make recommendations to Congress to end abuses of the physician self-referral law in radiation oncology enabled by the "in-office ancillary services exception."

17 Jun 2010

Degradable implant stimulates body to regenerate

In a medical emergency, a puncture of the cranium is commonly treated with an implant. While replacements made of titanium merely plug holes, a new kind of degradable implant stimulates the body to regenerate itself: It is custom-fit and disappears to the same extent that the bone regrows.

16 Jun 2010

TYRX successfully implants AIGISRx device in 10,000 patients in the U.S.

TYRX, Inc. announced today that it has successfully implanted its AIGISRx device in 10,000 patients in the United States. The AIGISRx device is an antibacterial mesh technology that securely holds a pacemaker or implantable cardioverter defibrillator in place to create a stable environment, while delivering antimicrobial agents, rifampin and minocycline. These antimicrobial agents have been shown to reduce infections associated with medical devices in multiple randomized controlled trials.

15 Jun 2010

Stryker's facilities in Michigan, US and Suzhou, China earn LEED certifications

Stryker Corporation announced today that two of its manufacturing facilities have earned Leadership in Energy & Environmental Design (LEED) certifications from the U.S. Green Building Council (USGBC). LEED is an internationally recognized green building certification system, developed by the USGBC, which provides a framework for identifying and implementing practical and measurable green building design, construction, operations and maintenance solutions.

From Stryker 14 Jun 2010

Aesculap receives FDA clearance for SterilContainer product line for use in STERIS V-PRO systems

Aesculap, Inc. is pleased to announce that the SterilContainer S product line has been cleared by the United States Food and Drug Administration (FDA), (510(k) number, K093649) for use in the STERIS Corporation's V-PRO 1 and V-PRO 1 Plus Low Temperature Sterilization Systems.

14 Jun 2010

First hospital in Mexico to use GORE HELEX Septal Occluder for transcatheter closure of ASD

W. L. Gore & Associates (Gore) today announced that Instituto Nacional De Cardiologia in Mexico City, Mexico, is the first hospital in the country to use the GORE® HELEX Septal Occluder for the transcatheter closure of an atrial septal defect (ASD). Department Chief, Dr. Carlos Zabal and Dr. Jose Garcia Montes of the Instituto Nacional de Cardiologia, in Mexico City, achieved the milestone procedure in March, 2010.

14 Jun 2010

Preliminary addition of Uroplasty to Russell Microcap Index

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced it has been included on a list of preliminary additions to the Russell Microcap Index posted by Russell Investments on June 11, 2010 on www.russell.com. These changes are expected to go into effect after the close of trading on Friday, June 25, 2010.

14 Jun 2010

PolyMedix awarded $150,000 grant to support development of antimicrobial sutures to reduce SSIs

A new discovery may help curb surgical site infections through the use of a novel antibiotic agent that can be incorporated into sutures. SSIs are the third most common hospital-acquired infection and may be associated with severe morbidity and mortality. Since more than 60% of SSIs occur in the area of the incision, the use of sutures coated with an antibacterial agent called PolyCides, created by Radnor, PA-based PolyMedix Inc., may reduce infection rates.

14 Jun 2010

Scientist succeeds in producing replica of human collagen from tobacco plants

A scientist at the Hebrew University of Jerusalem's Robert H. Smith Faculty of Agriculture, Food and Environment has succeeded in producing a replica of human collagen from tobacco plants - an achievement with tremendous commercial implications for use in a variety of human medical procedures.

11 Jun 2010

MAKO's RIO Robotic Arm Interactive Orthopedic System receives 2010 Gold Medical Design Excellence Award

MAKO Surgical Corp. announced that its RIO® Robotic Arm Interactive Orthopedic System has received a 2010 Gold Medical Design Excellence Award. RIO® is used to perform MAKOplasty® partial knee resurfacing, a treatment option for patients with early to mid-stage osteoarthritis of the knee.

11 Jun 2010

Orthopaedic Synergy acquires PRAXIM

Orthopaedic Synergy, Inc., is pleased to announce that our acquisition of PRAXIM, SA, Grenoble, France was successfully completed on May 18, 2010.

11 Jun 2010

Boston Scientific's TAXUS Element Paclitaxel-Eluting Coronary Stent System launched in Europe

Boston Scientific Corporation today announced the market launch and first implants of its TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System in the European Union and other CE Mark countries. The TAXUS Element Stent System is the Company's third-generation drug-eluting stent (DES) technology and incorporates a platinum chromium alloy with an innovative stent design and an advanced catheter delivery system. It received CE Mark approval last month, which included a specific indication for the treatment of diabetic patients.

10 Jun 2010

Curexo Technology's ROBODOC assists in first commercial hip replacement surgery

Curexo Technology Corporation made history on Wednesday, May 26, 2010 when its next-generation ROBODOC® Surgical System assisted Dr. William Bargar as he performed the first commercial hip replacement surgery on Warren Roberts of Davis, CA. Mr. Roberts had his left hip replacement using this robotic device in 1995 as a part of an FDA study. This recent surgery performed at Sutter General in Sacramento was for Mr. Roberts' right hip.

10 Jun 2010

DSM announces agreements with Biomedical Structures, Cortland and Secant Medical

DSM, which created and manufactures Dyneema Purity, the world's strongest Medical grade fiber, today announced agreements with Biomedical Structures, Cortland Company and Secant Medical. These companies' experience in processing Dyneema Purity fiber in biomedical textile structures offers medical device companies the ability to use various constructions of Dyneema Purity, including the recently launched Dyneema Purity BLUE, in commercial medical devices.

9 Jun 2010

Integra LifeSciences announces over 800 implantations of Vu a-POD fusion device

Integra LifeSciences announced today a major milestone in the commercialization of the Vu a-POD™ anterior lumbar intervertebral body fusion (ALIF) device. Launched in the U.S. in early 2009, the Vu a-Pod™ fusion device has now been implanted in over 800 patients in the U.S.

8 Jun 2010

Biomet Biologics initiates enrollment in MarrowStim P.A.D. Kit IDE trial for critical limb ischemia

Biomet, a global leader in the manufacture of orthopedic and biotechnology products, announced today that its subsidiary, Biomet Biologics, has enrolled the first subject into its multicenter, prospective, randomized, double-blind, placebo-controlled clinical trial for critical limb ischemia (CLI).

5 Jun 2010

Antiemetic-regimen with fosaprepitant injection provides similar protection against CINV as oral EMEND

Merck announced today results from a new non-inferiority trial of an antiemetic regimen containing fosaprepitant dimeglumine administered as a single intravenous (IV) 150-mg dose in combination with a 5-HT3 antagonist and dexamethasone compared with a three-day regimen of aprepitant with a 5-HT3 antagonist and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving a first cycle of cisplatin-based chemotherapy.

4 Jun 2010

Two-stage procedure reduces bone loss in oral implants

Researchers have found that less bone loss is experienced in an oral implant when a two-stage approach to surgery is used. Simultaneously inserted implants, which require one operation to transplant bone tissue and to insert implants into the jawbone, have shown excellent results. However, when the implants were inserted in a second operation about six months after the bone tissue grafts, crestal bone loss was reduced.

4 Jun 2010

Implants News and Research

NMT Medical receives preliminary results for CLOSURE I PFO/stroke and transient ischemic attack trial

First implantation of PyroTITAN Humeral Resurfacing Arthroplasty performed outside US in Australia

ASTRO urges MedPAC to recommend end to abuse of physician self-referral law in radiation oncology

Degradable implant stimulates body to regenerate

TYRX successfully implants AIGISRx device in 10,000 patients in the U.S.

Stryker's facilities in Michigan, US and Suzhou, China earn LEED certifications

Aesculap receives FDA clearance for SterilContainer product line for use in STERIS V-PRO systems

First hospital in Mexico to use GORE HELEX Septal Occluder for transcatheter closure of ASD

Preliminary addition of Uroplasty to Russell Microcap Index

PolyMedix awarded $150,000 grant to support development of antimicrobial sutures to reduce SSIs

Scientist succeeds in producing replica of human collagen from tobacco plants

MAKO's RIO Robotic Arm Interactive Orthopedic System receives 2010 Gold Medical Design Excellence Award

Orthopaedic Synergy acquires PRAXIM

Boston Scientific's TAXUS Element Paclitaxel-Eluting Coronary Stent System launched in Europe

Curexo Technology's ROBODOC assists in first commercial hip replacement surgery

DSM announces agreements with Biomedical Structures, Cortland and Secant Medical

Integra LifeSciences announces over 800 implantations of Vu a-POD fusion device

Biomet Biologics initiates enrollment in MarrowStim P.A.D. Kit IDE trial for critical limb ischemia

Antiemetic-regimen with fosaprepitant injection provides similar protection against CINV as oral EMEND

Two-stage procedure reduces bone loss in oral implants

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News